Lumos Pharma (LUMO)
(Delayed Data from NSDQ)
$2.80 USD
-0.01 (-0.18%)
Updated Apr 24, 2024 03:58 PM ET
After-Market: $2.90 +0.11 (3.76%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/01/2024
Time: -- |
3/2024 | $-1.21 | 0.00% |
Earnings Summary
For their last quarter, Lumos Pharma (LUMO) reported earnings of -$1.17 per share, beating the Zacks Consensus Estimate of $-1.18 per share. This reflects a positive earnings surprise of 0.85%. Look out for LUMO's next earnings release expected on May 01, 2024. For the next earning release, we expect the company to report earnings of -$1.21 per share, reflecting a year-over-year decrease of 35.96%.
Earnings History
Price & Consensus
Zacks News for LUMO
Exact Sciences (EXAS) Reports Q4 Loss, Tops Revenue Estimates
LUMO: What are Zacks experts saying now?
Zacks Private Portfolio Services